Novavax stock soars as FDA removes clinical hold on its COVID and influenza shot

Go back to Novavax stock soars as FDA removes clinical hold on its COVID and influenza shot

DA Davidson Starts monday.com Ltd. (MNDY) at Neutral

November 12, 2024 5:23 AM EST

DA Davidson analyst Lucky Schreiner initiates coverage on monday.com Ltd. (NASDAQ: MNDY) with a Neutral rating and a price target of $300.00.

The analyst comments "With this note, we are assuming coverage of monday.com with a NEUTRAL rating and $300 price target.... More

JPMorgan Defending monday.com Ltd. (MNDY)

November 11, 2024 4:06 PM EST

JPMorgan analyst Pinjalim Bora reiterated an Overweight rating and $350.00 price target on monday.com Ltd. (NASDAQ: MNDY).

The analyst comments "Monday reported a fine quarter in a choppy macro backdrop, with all key guided metrics landing ahead of consensus expectations as Monday marked a Rule of 65% quarter, in addition to the full year guide being reset higher. However, the beat-and-raise magnitude softened relative to historical norms and likely landed towards the low end of buy-side bars, making it challenging for... More